A microbial TLR2 agonist imparts macrophage-activating ability to apolipoprotein A-1

Journal of Immunology

Volumn 177, Issue 7, 2006, Pages 4826-4832

  Hasebe, Akira ^a   Pennock, Nathan D ^a   Mu, Hong Hua ^a   Chan, Fok V ^a   Taylor, Michael L ^a   Cole, Barry C ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALI; APOLIPOPROTEIN A1; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CYTOKINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 12P40; LIPOPEPTIDE; LIPOPROTEIN; MACROPHAGE ACTIVATING FACTOR; MACROPHAGE ACTIVATING LIPOPEPTIDE 2; OCTYL GLUCOSIDE; PROTEINASE K; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BACTERIAL INFECTION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAT TOLERANCE; HYDROLYSIS; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MACROPHAGE ACTIVATION; MASS SPECTROMETRY; MOUSE; MYCOPLASMA ARTHRITIDIS; NONHUMAN; PERITONEUM CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SPLEEN CELL;

EID: 33749139552     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.7.4826     Document Type: Article

References (43)

1. Washburn, L. R., and N. L. Somerson. 1979. Lipoptoteins as substitutes for serum in mycoplasma culture medium. J. Clin. Microbiol. 10: 586-589.
2. Razin, S., H. Efrati, S. Kutner, and S. Rottem. 1982. Cholesterol and phospholipid uptake by mycoplasmas. Rev. Infect. Dis. 4: S85-S92.
3. Cole, B. C., A. Sawitzke, and H. H. Mu. 2000. Mycoplasma anhritidis and its superantigen M. anhritidis mitogen as a model for inflammatory and autoimmune disease. In Effects of Microbes on the Immune System. M. W. Cunningham and R. S. Fujinami, eds. Lippincott, Williams and Wilkins, Philadelphia, pp. 93-107.
4. Mu, H. H., N. D. Pennock, J. Humphreys, C. J. Kirschning, and B. C. Cole. 2005. Engagement of Toll-like receptors by mycoplasmal superantigen: down-regulation of TLR2 by MAM/TLR4 interaction. Cell Microbiol. 7: 789-797.
5. Washburn, L. R., and B. C. Cole. 2002. Mycoplasma anhritidis pathogenicity: membrane, MAM and MAV1. In Molecular Biology and Pathogenicity of Mycoplamas. R. Herrmann and S. Razin, eds. Kluver Acdemic/Plenum Publishers, New York, pp. 473-489.
6. Cole, B. C., H. H. Mu, N. D. Pennock, A. Hasebe, F. V. Chan, L. R. Washburn, and M. R. Peltier. 2005. Isolation and partial purification of macrophage- and dendritic cell-activating components from Mycoplasma anhritidis: association with organism virulence and involvement with Toll-like receptor 2. Infect. Immun. 73: 6039-6047.
7. Washburn, L. R., E. J. Miller, S. Mukherjee, and D. Dannenbring. 2004. Mycoplasma anhritidis bacteriophage MAV1 prophage integration, deletions, and strain-related polymorphisms. Plasmid 52: 31-47.
8. Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, and D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274: 33419-33425.
9. Medzhitov, R., and C. Janeway, Jr. 2000. The Toll receptor family and microbial recognition. Trends Microbiol. 8: 452-456.
10. Takeuchi, O., A. Kaufmann, K. Grote, T. Kawai, K. Hoshino, M. Morr, P. F. Muhlradt, and S. Akira. 2000. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164: 554-557.
11. Morr, M., O. Takeuchi, S. Akira, M. M. Simon, and P. F. Muhlradt. 2002. Differential recognition of structural details of bacterial lipopeptides by Toll-like receptors. Eur. J. Immunol. 32: 3337-3347.
12. Akira, S. 2001. Toll-like receptors and innate immunity. Adv. Immunol. 78: 1-56.
13. Janeway, C. A., Jr., and R. Medzhitov. 1998. Introduction: the role of innate immunity in the adaptive immune response. Semin. Immunol. 10: 349-350.
14. Pasare, C., and R. Medzhitov. 2004. Toll-like receptors and acquired immunity. Semin. Immunol. 16: 23-26.
15. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5: 987-995.
16. Mandal, K., M. Jahangiri, and Q. Xu. 2004. Autoimmunity to heat shock proteins in atherosclerosis. Autoimmun. Rev. 3: 31-37.
17. Ludewig, B., P. Krebs, and E. Scandella. 2004. Immunopathogenesis of atherosclerosis. J. Leukocyte Biol. 76: 300-306.
18. Redecke, V., H. Hacker, S. K. Datta, A. Fermin, P. M. Pitha, D. H. Broide, and E. Raz. 2004. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 172: 2739-2743.
19. Mullick, A. E., P. S. Tobias, and L. K. Curtiss. 2005. Modulation of atherosclerosis in mice by Toll-like receptor 2. J. Clin. Invest. 115: 3149-3156.
20. Kol, A., and P. Libby. 1998. The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations. Trends Cardiovasc. Med. 8: 191-199.
21. Atkin, C. L., S. Wei, and B. C. Cole. 1994. The Mycoplasma arthritidis superantigen MAM: purification and identification of an active peptide. Infect. Immun. 62: 5367-5375.
22. Morton, R. E., and T. A. Evans. 1992. Modification of the bicinchoninic acid protein assay to eliminate lipid interference in determining lipoprotein protein content. Anal. Biochem. 204: 332-334.
23. Shibata, K., A. Hasebe, T. Into, M. Yamada, and T. Watanabe. 2000. The N-terminal lipopeptide of a 44-kDa membrane-bound lipoprotein of Mycoplasma salivarium is responsible for the expression of intercellular adhesion molecule-1 on the cell surface of normal human gingival fibroblasts. J. Immunol. 165: 6538-6544.
24. Wallis, R. S., M. Amir-Tahmasseb, and J. J. Ellner. 1990. Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte Western blot. Proc. Natl. Acad. Sci. USA 87: 3348-3352.
25. Solomons, T. W., and C. B. Fryhle. 2000. Organic Chemistry, 7th Ed. John Wiley & Sons, Indianapolis.
26. Hasebe, A., A. Yoshimura, T. Into, H. Kataoka, S. Tanaka, S. Arakawa, H. Ishikura, D. T. Golenbock, T. Sugaya, N. Tsuchida, et al. 2004. Biological activities of Bacteroides forsythus lipoproteins and their possible pathological roles in periodontal disease. Infect. Immun. 72: 1318-1325.
27. Hantke, K., and V. Braun. 1973. Covalent binding of lipid to protein: diglyceride and amide-linked fatty acid at the N-terminal end of the murein-lipoprotein of the Escherichia coli outer membrane. Eur. J. Biochem. 34: 284-296.
28. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
29. Sellati, T. J., D. A. Bouis, R. L. Kitchens, R. P. Darveau, J. Pugin, R. J. Ulevitch, S. C. Gangloff, S. M. Goyert, M. V. Norgard, and J. D. Radolf. 1998. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J. Immunol. 160: 5455-5564.
30. Davis, K. L., and K. S. Wise. 2002. Site-specific proteolysis of the MALP-404 lipoprotein determines the release of a soluble selective lipoprotein-associated motif-containing fragment and alteration of the surface phenotype of Mycoplasma fermentans. Infect. Immun. 70: 1129-1135.
31. Smith, P. F. 1959. Cholesterol esterase activity of pleuropneumonialike organisms. J. Bacteriol. 77: 682-689.
32. Oshima, T., R. Ozono, Y. Yano, Y. Oishi, H. Teragawa, Y. Higashi, M. Yoshizumi, and M. Kambe. 2005. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J. Am. Coll. Cordiol. 45: 1219-1222.
33. Kuo, C. C., A. M. Gown, E. P. Benditt, and J. T. Grayston. 1993. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler. Thromb. 13: 1501-1504.
34. Arcari, C. M., C. A. Gaydos, F. J. Nieto, M. Krauss, and K. E. Nelson. 2005. Association between Chlamydia pneumoniae and acute myocardial infarction in young men in the United States military: the importance of timing of exposure measurement. Clin. Infect. Dis. 40: 1123-1130.
35. Ngeh, J., S. Gupta, C. Goodbourn, and G. McElligott. 2004. Mycoplasma pneumoniae in elderly patients with stroke: a case-control study on the seroprevalence of M. pneumoniae in elderly patients with acute cerebrovascular disease: the M-PEPS Study. Cerebrovasc. Dis. 17: 314-319.
36. Ngeh, J., and C. Goodbourn. 2005. Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila in elderly patients with stroke (C-PEPS, M-PEPS, L-PEPS): a case-control study on the infectious burden of atypical respiratory pathogens in elderly patients with acute cerebrovascular disease. Stroke 36: 259-265.
37. Haraszthy, V. I., J. J. Zambon, M. Trevisan, M. Zeid, and R. J. Genco. 2000. Identification of periodontal pathogens in atheromatous plaques. J. Periodontol. 71: 1554-1560.
38. Desvarieux, M., R. T. Demmer, T. Rundek, B. Boden-Albala, D. R. Jacobs, Jr., R. L. Sacco, and P. N. Papapanou. 2005. Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 111: 576-582.
39. Gibson, F. C. III, H. Yumoto, Y. Takahashi, H. H. Chou, and C. A. Genco. 2006. Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. J. Dent. Res. 85: 106-121.
40. Laberge, M. A., K. J. Moore, and M. W. Freeman. 2005. Atherosclerosis and innate immune signaling. Ann. Med. 37: 130-140.
41. Frank, P. G., and Y. L. Marcel. 2000. Apolipoprotein A-I: structure-function relationships. J. Lipid Res. 41: 853-872.
42. Van Lenten, B. J., S. Y. Hama, F. C. de Beer, D. M. Stafforini, T. M. McIntyre, S. M. Prescott, B. N. La Du, A. M. Fogelman, and M. Navab. 1995. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J. Clin. Invest. 96: 2758-2767.
43. Navab, M., G. M. Anantharamaiah, and A. M. Fogelman. 2005. The role of high-density lipoprotein in inflammation. Trends Cardiovasc. Med. 15: 158-161.